Carpal Tunnel Syndrome Assessment With Ultrasonography: A Comparison Between Non-diabetic and Diabetic Patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Chung Ho | - |
dc.contributor.author | Choi, Hanboram | - |
dc.contributor.author | Yoon, Joon Shik | - |
dc.contributor.author | Kang, Seok | - |
dc.date.accessioned | 2021-09-02T15:13:13Z | - |
dc.date.available | 2021-09-02T15:13:13Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-02 | - |
dc.identifier.issn | 2234-0645 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/77466 | - |
dc.description.abstract | Objective To investigate the diagnostic value of cross-sectional area (CSA) and wrist to forearm ratio (WFR) in patients with electro-diagnosed carpal tunnel syndrome (CTS) with or without diabetes mellitus (DM). Methods We retrospectively studied 256 CTS wrists and 77 healthy wrists in a single center between January 1, 2008 and January 1, 2013. The CSA and WFR were calculated for each wrist. Patients were classified into four groups according to the presence of DM and CTS: group 1, non-DM and non-CTS patients; group 2, non-DM and CTS patients; group 3, DM and non-CTS patients; and group 4, DM and CTS patients. To determine the optimal cut-off value, receiver operating characteristic (ROC) curve analysis was performed. Results The CSA and WFR were significantly different among the groups (p < 0.001). The ROC curve analysis of non-DM patients revealed CSA >= 10.0 mm(2) and WFR >= 1.52 as the most powerful diagnostic values of CTS. The ROC curve analysis revealed CSA >= 12.5 mm(2) and WFR >= 1.87 as the most powerful diagnostic values of CTS. Conclusion Ultrasonographic assessment for the diagnosis of CTS requires a particular cut-off value for diabetic patients. Based on the ROC analysis results, improved accurate diagnosis is possible if WFR can be applied regardless of presence or absence of DM. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD REHABILITATION MEDICINE | - |
dc.subject | NERVE | - |
dc.subject | ULTRASOUND | - |
dc.subject | PATHOPHYSIOLOGY | - |
dc.subject | POLYNEUROPATHY | - |
dc.subject | SONOGRAPHY | - |
dc.title | Carpal Tunnel Syndrome Assessment With Ultrasonography: A Comparison Between Non-diabetic and Diabetic Patients | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoon, Joon Shik | - |
dc.contributor.affiliatedAuthor | Kang, Seok | - |
dc.identifier.doi | 10.5535/arm.2018.42.1.85 | - |
dc.identifier.scopusid | 2-s2.0-85042792661 | - |
dc.identifier.wosid | 000426251300011 | - |
dc.identifier.bibliographicCitation | ANNALS OF REHABILITATION MEDICINE-ARM, v.42, no.1, pp.85 - 91 | - |
dc.relation.isPartOf | ANNALS OF REHABILITATION MEDICINE-ARM | - |
dc.citation.title | ANNALS OF REHABILITATION MEDICINE-ARM | - |
dc.citation.volume | 42 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 85 | - |
dc.citation.endPage | 91 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002317790 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Rehabilitation | - |
dc.relation.journalWebOfScienceCategory | Rehabilitation | - |
dc.subject.keywordPlus | NERVE | - |
dc.subject.keywordPlus | ULTRASOUND | - |
dc.subject.keywordPlus | PATHOPHYSIOLOGY | - |
dc.subject.keywordPlus | POLYNEUROPATHY | - |
dc.subject.keywordPlus | SONOGRAPHY | - |
dc.subject.keywordAuthor | Carpal tunnel syndrome | - |
dc.subject.keywordAuthor | Ultrasonography | - |
dc.subject.keywordAuthor | Electrodiagnosis | - |
dc.subject.keywordAuthor | Diabetes mellitus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.